Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD4 Deficiency”

310 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 310 results

Not applicableStudy completedNCT00002080
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia
Not applicableStudy completedNCT00000947
What this trial is testing

Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 850
Testing effectiveness (Phase 2)Study completedNCT00002185
What this trial is testing

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Who this might be right for
Sarcoma, KaposiHIV Infections
Agouron Pharmaceuticals 20
Early research (Phase 1)Ended earlyNCT00757250
What this trial is testing

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

Who this might be right for
HIV Infections
US Biotest, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT01299948
What this trial is testing

Progression of HIV-Disease Under Low Dose Corticosteroids

Who this might be right for
HIV Disease Progression
Medical Mission Institute, Germany 326
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Large-scale testing (Phase 3)Study completedNCT00002389
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Early research (Phase 1)Study completedNCT00000663
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Not applicableStudy completedNCT00006298
What this trial is testing

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 125
Large-scale testing (Phase 3)Study completedNCT03403569
What this trial is testing

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

Who this might be right for
HIV-infection/AIDS
Peking Union Medical College Hospital 353
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableNot Yet RecruitingNCT06889142
What this trial is testing

Impact of NMN Supplementation on CD4+ T Cell Recovery in HIV Patients With Immunological Failure

Who this might be right for
Human Immunodeficiency Virus
TriHealth Inc. 7
Not applicableStudy completedNCT00908544
What this trial is testing

New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients

Who this might be right for
HIV Infections
MUC Research GmbH 47
Testing effectiveness (Phase 2)Study completedNCT00000712
What this trial is testing

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Large-scale testing (Phase 3)UnknownNCT01289106
What this trial is testing

Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects

Who this might be right for
HIV Infection
Chiang Mai University 132
Large-scale testing (Phase 3)Study completedNCT00398996
What this trial is testing

Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Who this might be right for
HIV InfectionsTuberculosis
Centre for the AIDS Programme of Research in South Africa 642
Testing effectiveness (Phase 2)Study completedNCT00071240
What this trial is testing

Growth Hormone to Increase Immune Function in People With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 22
Not applicableStudy completedNCT00000883
What this trial is testing

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 636
Not applicableStudy completedNCT00491556
What this trial is testing

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 102
Next Page